Open AccessPsycho-behavioral factors associated with neurocognitive performance among people living with HIV on antiretroviral therapy in Accra, Ghana
Author(s) -
Nana Yaw Asiedu,
Irene A. Kretchy,
Emmanuel Asampong
Publication year - 2020
Publication title -
african health sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.391
H-Index - 44
eISSN - 1729-0503
pISSN - 1680-6905
DOI - 10.4314/ahs.v20i2.6
Subject(s) - neurocognitive , medicine , dementia , psychological intervention , depression (economics) , neuropsychology , activities of daily living , clinical psychology , human immunodeficiency virus (hiv) , psychiatry , cognition , gerontology , family medicine , disease , economics , macroeconomics
Background: It is estimated that almost half of all people living with HIV have some form of neurocognitive impairment, but few studies have looked at the risk of neurocognitive impairment and its associated factors in Ghana, due in part to limited resources for such testing.
Objective: To examine neurocognitive performance in a group of Ghanaians living with HIV and possible factors that contribute to their performance.
Methods: One hundred and four patients were assessed using a selection of brief non-invasive neuropsychological assess- ments as well as the International HIV Dementia Scale. Psycho-behavioural factors (alcohol use, depression, and medication adherence) as well as demographic characteristics and functional daily activities were assessed to determine their association with neurocognitive performance, using linear regression and receiver operating characteristic analyses.
Results: About 48% of the participants met the criteria for risk of neurocognitive impairment. Age, education, and symp- toms of depression were found to be significantly associated with the risk of impairment.
Conclusion: Some people living with HIV showed risk of neurocognitive impairment, which was significantly associated with education, age and depressive symptoms. It is therefore important to consider routine neurocognitive screening in HIV management to recognize any risks for early interventions.
Keywords: ART adherence; depression; neurologic disease.